selected scholarly activity
-
conferences
- A pilot study assessing adequacy of epinephrine autoinjector needle length to deliver epinephrine intramuscularly in adult patients with food and venom allergy. Allergy. European Journal of Allergy and Clinical Immunology. 569-569. 2013
- The effectiveness of an asthma control questionnaire (ACQ) in predicting clinical decisions in an inhaled corticosteroid tapering protocol. Journal of Allergy and Clinical Immunology. S293-S293. 2002
- The utility of skin testing in patients with reactions to a meningitis vaccine (MV). Journal of Allergy and Clinical Immunology. S146-S146. 2002
-
journal articles
- Tezepelumab in patients with allergic and eosinophilic asthma. Acta Allergologica. 2023
- A case of possible anaphylaxis to ASA and structurally unrelated NSAIDs. Allergy, Asthma and Clinical Immunology. 19:81. 2023
- Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach. Journal of Allergy and Clinical Immunology. 152:309-325. 2023
- Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study. Allergy, Asthma and Clinical Immunology. 19:54. 2023
- Evening ingestion as a potential reaction cofactor during peanut oral immunotherapy in children. Journal of Allergy and Clinical Immunology: In Practice. 11:1964-1966.e2. 2023
- A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis. Allergy, Asthma and Clinical Immunology. 19:48. 2023
- Comparing the risk of anaphylaxis requiring epinephrine in oral immunotherapy and subcutaneous immunotherapy: A review of recent Canadian real-world literature. J Allergy Clin Immunol Glob. 2:100080-100080. 2023
- Canadian Health Care Professionals’ Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional Survey. Lung. 201:47-55. 2023
- Food protein–induced enterocolitis syndrome in response to salmon roe and trout roe. J Allergy Clin Immunol Glob. 2:122-123. 2023
- Geographical discrepancy in oral food challenge utilization based on Canadian billing data. Allergy, Asthma and Clinical Immunology. 19:5. 2023
- Canadian multidisciplinary expert consensus on the use of biologics in upper airways: A Delphi study. Journal of Otolaryngology - Head and Neck Surgery. 52:30. 2023
- Epinephrine autoinjectors: individualizing device and dosage to optimize anaphylaxis management in the community setting. Allergy and Asthma Proceedings. 44:45-50. 2023
- International recommendations on epinephrine auto-injector doses often differ from standard weight-based guidance: a review and clinical proposals. Allergy, Asthma and Clinical Immunology. 18:102. 2022
- Modified oral food challenge protocol approach in the diagnosis of Food Protein-Induced Enterocolitis Syndrome. Allergy, Asthma and Clinical Immunology. 18:8. 2022
- Telemedicine in allergy/immunology in the era of COVID-19: a Canadian perspective. Allergy, Asthma and Clinical Immunology. 18:16. 2022
- The need for a food allergy educator program for allied healthcare professionals in Canada. Allergy, Asthma and Clinical Immunology. 18:62. 2022
- Peanut, soy, and emerging legume allergy in Canada. J Allergy Clin Immunol Glob. 1:319-321. 2022
- Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study. Allergy, Asthma and Clinical Immunology. 18:70. 2022
- The perceived impact of pediatric food allergy on mental health care needs and supports: A pilot study. J Allergy Clin Immunol Glob. 1:67-72. 2022
- Canadian parent perceptions of oral food challenges: A qualitative analysis. Pediatric Allergy and Immunology. 33:e13698. 2022
- Comparison of weight per volume and protein nitrogen units in non-standardized allergen extracts: implications for prescribing subcutaneous immunotherapy. Allergy, Asthma and Clinical Immunology. 17:92. 2021
- Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case report. Allergy, Asthma and Clinical Immunology. 17:58. 2021
- Systemic reactions to subcutaneous allergen immunotherapy: real-world cause and effect modelling. Allergy, Asthma and Clinical Immunology. 17:65. 2021
- Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts. Allergy, Asthma and Clinical Immunology. 17:3. 2021
- The pharmacokinetics of epinephrine/adrenaline autoinjectors. Allergy, Asthma and Clinical Immunology. 17:25. 2021
- Chronic cough: Investigations, management, current and future treatments. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. 5:404-416. 2021
- Multicenter real-world experience with epinephrine 0.5 mg dosing for anaphylaxis with allergen immunotherapy. Immunotherapy. 13:1325-1331. 2021
- The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. Journal of Allergy and Clinical Immunology: In Practice. 9:3546-3567. 2021
- The hidden allergen: Triton X-100, a derivative of polyethylene glycol. Journal of Allergy and Clinical Immunology: In Practice. 9:2941-2941. 2021
- Adrenal suppression from exogenous glucocorticoids: Recognizing risk factors and preventing morbidity. Paediatrics and Child Health. 26:242-247. 2021
- La suppression surrénalienne causée par les glucocorticoïdes exogènes : en reconnaître les facteurs de risque et en prévenir les effets. Paediatrics and Child Health. 26:248-254. 2021
- Impact of age on adherence and efficacy of peanut oral‐immunotherapy using a standardized protocol. Pediatric Allergy and Immunology. 32:783-786. 2021
- Most Burdensome Food Allergy in Childcare Centers and Schools: A Cross-sectional Study. Health Behavior and Policy Review. 8:194-201. 2021
- Amoxicillin oral provocation challenge in a primary care clinic: a descriptive analysis. CMAJ open. 9:E394-E399. 2021
- Sesame allergy a time burden for families of children with multiple food allergies. Journal of Allergy and Clinical Immunology: In Practice. 9:1753-1755.e1. 2021
- A contemporary look at allergic conjunctivitis. Allergy, Asthma and Clinical Immunology. 16:5. 2020
- A single centre retrospective study of systemic reactions to subcutaneous immunotherapy. Allergy, Asthma and Clinical Immunology. 16:93. 2020
- Adults with possible food protein-induced enterocolitis syndrome with crustacean ingestion. Allergy, Asthma and Clinical Immunology. 16:99. 2020
- CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy. Allergy, Asthma and Clinical Immunology. 16:20. 2020
- Correction to: The International/Canadian Hereditary Angioedema Guideline. Allergy, Asthma and Clinical Immunology. 16:33. 2020
- Epinephrine auto-injector needle length. Allergy, Asthma and Clinical Immunology. 16:24. 2020
- Increasing Awareness of the Low Risk of Severe Reaction at Infant Peanut Introduction: Implications During COVID-19 and Beyond. Journal of Allergy and Clinical Immunology: In Practice. 8:3259-3260. 2020
- Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report. Journal of Allergy and Clinical Immunology: In Practice. 8:2920-2936.e1. 2020
- Milk allergy most burdensome in multi‐food allergic children. Pediatric Allergy and Immunology. 31:827-834. 2020
- Appointment characteristics during COVID-19 restrictions: A Canadian allergy/immunology centre perspective. Journal of Allergy and Clinical Immunology: In Practice. 8:2837-2838. 2020
- A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services. Journal of Allergy and Clinical Immunology: In Practice. 8:2125-2134. 2020
- Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”. Journal of Allergy and Clinical Immunology: In Practice. 8:2450-2452. 2020
- Intentional poisoning with peanut as a cause of recurrent anaphylaxis. Annals of Allergy, Asthma and Immunology. 124:622-623. 2020
- Lignes directrices canadiennes en immunothérapie orale : nouvelle méthodologie pour des recommandations axées sur le patient et reposant sur les évidences cliniques et les principes éthiques. Revue Francaise d'Allergologie et d'Immunologie Clinique. 60:219-221. 2020
- COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic. Journal of Allergy and Clinical Immunology: In Practice. 8:1477-1488.e5. 2020
- Epinephrine autoinjectors. Annals of Allergy, Asthma and Immunology. 124:449-450. 2020
- Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here?. Journal of Allergy and Clinical Immunology. 145:1153-1156. 2020
- The International/Canadian Hereditary Angioedema Guideline. Allergy, Asthma and Clinical Immunology. 15:72. 2019
- ICER report for peanut OIT comes up short. Annals of Allergy, Asthma and Immunology. 123:430-432. 2019
- Adrenal suppression from glucocorticoids: preventing an iatrogenic cause of morbidity and mortality in children. BMJ Paediatrics Open. 3:e000569-e000569. 2019
- Implications of variation of epinephrine auto-injector needle length. Annals of Allergy, Asthma and Immunology. 123:89-94. 2019
- Point-of-care ultrasonography in the allergy and immunology clinic. Annals of Allergy, Asthma and Immunology. 123:42-47. 2019
- Tissue compression and epinephrine deposition. Journal of Allergy and Clinical Immunology: In Practice. 7:2096-2097. 2019
- CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens. Allergy, Asthma and Clinical Immunology. 14:1. 2018
- Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective. Allergy, Asthma and Clinical Immunology. 14:68. 2018
- Unintentional injection to the bone with a pediatric epinephrine auto-injector. Allergy, Asthma and Clinical Immunology. 14:32. 2018
- Authors’ response. Annals of Allergy, Asthma and Immunology. 121:644-645. 2018
- Allergen-specific immunotherapy. Allergy, Asthma and Clinical Immunology. 14:53. 2018
- Allergic rhinitis. Allergy, Asthma and Clinical Immunology. 14:51. 2018
- An introduction to immunology and immunopathology. Allergy, Asthma and Clinical Immunology. 14:49. 2018
- Anaphylaxis. Allergy, Asthma and Clinical Immunology. 14:54. 2018
- Asthma. Allergy, Asthma and Clinical Immunology. 14:50. 2018
- Introduction from the Editors. Allergy, Asthma and Clinical Immunology. 14:48. 2018
- Non-IgE-mediated food hypersensitivity. Allergy, Asthma and Clinical Immunology. 14:56-56. 2018
- Epinephrine auto-injector needle lengths: Can both subcutaneous and periosteal/intraosseous injection be avoided?. Annals of Allergy, Asthma and Immunology. 120:648-653.e1. 2018
- Asthma biomarkers in the age of biologics. Allergy, Asthma and Clinical Immunology. 13:48. 2017
- Erratum to: Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?. Allergy, Asthma and Clinical Immunology. 13:33. 2017
- High rate of house dust mite sensitization in a shrimp allergic southern Ontario population. Allergy, Asthma and Clinical Immunology. 13:5. 2017
- Inadequacy of current pediatric epinephrine autoinjector needle length for use in infants and toddlers. Annals of Allergy, Asthma and Immunology. 118:719-725.e1. 2017
- Endotypes of difficult-to-control asthma in inner-city African American children. PLoS ONE. 12:e0180778-e0180778. 2017
- Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?. Allergy, Asthma and Clinical Immunology. 12:11. 2016
- Venom allergy testing: is a graded approach necessary?. Annals of Allergy, Asthma and Immunology. 116:49-51. 2016
- Allergen immunotherapy in pregnancy. Allergy, Asthma and Clinical Immunology. 11:31. 2015
- CSACI position statement: epinephrine auto-injectors and children < 15 kg. Allergy, Asthma and Clinical Immunology. 11:20. 2015
- CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma. Allergy, Asthma and Clinical Immunology. 11:9. 2015
- Therapeutic potential of anti-IL-6 therapies for granulocytic airway inflammation in asthma. Nature Chemical Biology. 11:14. 2015
- Administration and Burden of Subcutaneous Immunotherapy for Allergic Rhinitis in U.S. and Canadian Clinical Practice. Journal of managed care & specialty pharmacy. 21:982-990. 2015
- A retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma. Allergy, Asthma and Clinical Immunology. 10:64. 2014
- Auto-injector needle length may be inadequate to deliver epinephrine intramuscularly in women with confirmed food allergy. Allergy, Asthma and Clinical Immunology. 10:39. 2014
- Children under 15 kg with food allergy may be at risk of having epinephrine auto-injectors administered into bone. Allergy, Asthma and Clinical Immunology. 10:40. 2014
- Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis. Allergy, Asthma and Clinical Immunology. 10:55. 2014
- Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections. Allergy, Asthma and Clinical Immunology. 10:22. 2014
- The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children. Allergy, Asthma and Clinical Immunology. 10:53. 2014
- Value of skin testing children with a family history of food allergy before ingestion of suspect food allergens. Allergy, Asthma and Clinical Immunology. 10:a29. 2014
- A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy, Asthma and Clinical Immunology. 9:30. 2013
- CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults. Allergy, Asthma and Clinical Immunology. 9:24. 2013
- The utility of using fiberoptic rhinoscopy in the diagnosis of nasal polyps. Allergy, Asthma and Clinical Immunology. 9:38. 2013
- Skin prick testing with extensively heated milk or egg products helps predict the outcome of an oral food challenge: a retrospective analysis. Allergy, Asthma and Clinical Immunology. 8:5. 2012
- Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy. Allergy, Asthma and Clinical Immunology. 7:13. 2011
- Allergen-specific immunotherapy. Allergy, Asthma and Clinical Immunology. 7:S5. 2011
- Allergic rhinitis. Allergy, Asthma and Clinical Immunology. 7:S3. 2011
- An introduction to immunology and immunopathology. Allergy, Asthma and Clinical Immunology. 7:S1. 2011
- Anaphylaxis. Allergy, Asthma and Clinical Immunology. 7:S6. 2011
- Asthma. Allergy, Asthma and Clinical Immunology. 7:S2. 2011
- Introduction from the Editors. Allergy, Asthma and Clinical Immunology. 7:I1. 2011
- Omalizumab: Practical considerations regarding the risk of anaphylaxis. Allergy, Asthma and Clinical Immunology. 6:32. 2010
- Skin prick testing in patients using beta-blockers: a retrospective analysis. Allergy, Asthma and Clinical Immunology. 6:2. 2010
- Management of asthma in adults. CANADIAN MEDICAL ASSOCIATION JOURNAL. 181:915-922. 2009
- Diagnosis of asthma in adults. CANADIAN MEDICAL ASSOCIATION JOURNAL. 181:E210-E220. 2009
- Impact of Desloratadine on Symptoms and Quality of Life in Subjects with Chronic Idiopathic Urticaria: A Multicenter, Practice‐based Study. Archives of Drug Information. 1:63-69. 2008
- Asthma Worsenings: Approaches to Prevention and Management from the Asthma Worsenings Working Group. Canadian Respiratory Journal. 15:1B-19B. 2008
- The Link between Allergic Rhinitis and Asthma: A Role for Antileukotrienes?. Canadian Respiratory Journal. 15:91-98. 2008
- Modifying the allergic response in asthma*. Canadian Pharmacists Journal. 140:s11-s11.e1. 2007
- Rhinitis: A Practical and Comprehensive Approach to Assessment and Therapy. Journal of Otolaryngology - Head and Neck Surgery. 36:S5-S5. 2007
- Rhinitis: An Executive Summary of a Practical and Comprehensive Approach to Assessment and Therapy. Journal of Otolaryngology - Head and Neck Surgery. 36:S1-S1. 2007
- Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI). Allergy, Asthma and Clinical Immunology. 2:47-61. 2006
- Desloratadine for allergic rhinitis. Expert Review of Clinical Immunology. 2:209-224. 2006
- Consensus Guidelines on Practical Issues of Immunotherapy–Canadian Society of Allergy and Clinical Immunology (CSACI). Allergy, Asthma and Clinical Immunology. 02:47-47. 2006
- The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine. Acta Allergologica. 59:4-16. 2004
- Adult Asthma Consensus Guidelines Update 2003. Canadian Respiratory Journal. 11:9A-18A. 2004
- Reported Case of Severe Hepatotoxicity Likely due to Fluconazole and <i>Not</i> Desloratadine. Acta Haematologica. 112:177-178. 2004
- An unusual case of bilateral auriculotemporal syndrome presenting to an allergist. Annals of Allergy, Asthma and Immunology. 89:104-105. 2002
- Tourette's Syndrome in Patients Referred for Allergy Evaluation. Annals of Allergy, Asthma and Immunology. 79:347-349. 1997
-
other